Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children.
Ferreras-Antolín L; Irwin A; Atra A; Chapelle F; Drysdale SB; Emonts M; McMaster P; Paulus S; Patel S; Rompola M; Vergnano S; Whittaker E; Warris A.
Pediatr Infect Dis J
(Unknown)
Published: 2022
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Chil…
Morin S; Lallemant M; Garcia-Prats A; Lewis L; Watkins M; Giaquinto C; Valentin M; Penazzato M; Reeder JC; Global Accelerator for Paediatric Formulations (GAP-f).
Pediatr Infect Dis J
(Unknown)
Published: 2022
Etiology and Clinical Characteristics of Severe Pneumonia Among Young Children in Thailand: Pneumonia Etiology Research…
Bunthi C; Rhodes J; Thamthitiwat S; Higdon MM; Chuananon S; Amorninthapichet T; Paveenkittiporn W; Chittaganpitch M; Sawatwong P; Hammitt LL; Feikin DR; Murdoch DR; Deloria-Knoll M; O'Brien KL; Prosperi C; Maloney SA; Baggett HC; Akarasewi P.
Pediatr Infect Dis J
(Unknown)
Published: 2021
Racial and Ethnic Disparities in Multisystem Inflammatory Syndrome in Children in the United States, March 2020 to Febr…
Stierman B; Abrams JY; Godfred-Cato SE; Oster ME; Meng L; Yip L; Patel P; Balachandran N; Prezzato E; Pierce T; Hsu KK; Burns M; Peterson Pompa X; Lauro P; Hartley A; Jones C; Gretsch S; Reid H; Lim S; Campbell AP; Belay ED.
Pediatr Infect Dis J
(Unknown)
Published: 2021
Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phas…
Kim JH; Drame M; Puthanakit T; Chiu NC; Supparatpinyo K; Huang LM; Chiu CH; Chen PY; Hwang KP; Danier J; Friel D; Salaun B; Woo W; Vaughn DW; Innis B; Schuind A.
Pediatr Infect Dis J
(Unknown)
Published: 2021